Ligand validation:2CNV

ASP: ASPARTIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2CNV_ASP_A_1309	10%	34%	0.312	0.82	1.19	1.42	1	2	1	0	100%	0.4667
2CNV_ASP_A_1310	2%	33%	0.345	0.631	1.14	1.52	1	2	1	0	100%	0.5
2CNU_ASP_A_1309	8%	15%	0.302	0.785	1.86	1.91	3	3	11	0	100%	0.7
2F5X_ASP_B_902	100%	25%	0.041	0.987	1.1	1.93	1	2	1	0	100%	1
7U6M_ASP_A_400	100%	27%	0.042	0.987	1.32	1.59	1	3	0	0	100%	1
6PAE_ASP_A_401	99%	18%	0.047	0.981	1.99	1.56	3	3	0	0	100%	1
6JL5_ASP_F_402	99%	30%	0.057	0.99	1.26	1.53	-	2	0	0	100%	1
2V25_ASP_B_1234	99%	39%	0.052	0.982	1	1.37	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.